Evidence map›Paper›PMID 42381110›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026

Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [

Minal Padden-Modi, Jan Taprogge, Peter Dutey-Magni, Carolina G S Cauduro, Matthew D Blackledge, Hoda Abdel-Aty, Iain Murray, Nabil Hujairi, Nina Tunariu, Nick James

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Minal Padden-Modi *Radiotherapy and Imaging Department, Institute of Cancer Research, The Institute of Cancer Research, 123 Old Brompton Rd, South Kensington, London, SW7 3RP, UK. minal.padden-modi@icr.ac.uk.
Jan Taprogge *Radioisotope Physics, The Royal Marsden Hospital NHSFT & The Institute of Cancer Research, 15 Cotswold Rd, Sutton, London, SM2 5NG, UK.
Peter Dutey-MagniMedicines Research Council, Clinical Trials Unit, University College London, 90 High Holborn, London, WC1V 6LJ, UK.
Carolina G S CauduroRadiotherapy and Imaging Department, Institute of Cancer Research, The Institute of Cancer Research, 123 Old Brompton Rd, South Kensington, London, SW7 3RP, UK.
Matthew D BlackledgeRadiotherapy and Imaging Department, Institute of Cancer Research, The Institute of Cancer Research, 123 Old Brompton Rd, South Kensington, London, SW7 3RP, UK.
Hoda Abdel-AtyRadiotherapy and Imaging Department, Institute of Cancer Research, The Institute of Cancer Research, 123 Old Brompton Rd, South Kensington, London, SW7 3RP, UK.
Iain MurrayRadioisotope Physics, The Royal Marsden Hospital NHSFT & The Institute of Cancer Research, 15 Cotswold Rd, Sutton, London, SM2 5NG, UK.
Nabil HujairiRadiology Department, The Royal Marsden Hospital NHS FT, Downs Road, Sutton, Surrey, SM2 5PT, UK.
Nina TunariuRadiology Department, The Royal Marsden Hospital NHS FT, Downs Road, Sutton, Surrey, SM2 5PT, UK.
Nick JamesRadiotherapy and Imaging Department, Institute of Cancer Research, The Institute of Cancer Research, 123 Old Brompton Rd, South Kensington, London, SW7 3RP, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study evaluates the utility of quantitative imaging biomarkers derived from whole-body diffusion-weighted MRI (WB-DWMRI) and [

methodsTwenty-two patients with mCRPC who underwent WB-DWMRI and [

results65 bone lesions and 30 lymph nodes were analysed pre- and post-therapy. Forty-four (68%) bone and 16 (53%) lymph nodes lesions responded to treatment. SUV

conclusionsBaseline PSMA SUV

Indexed as

Diffusion Magnetic Resonance ImagingHeterocyclic Compounds, 1-RingLutetiumOrganometallic CompoundsPositron Emission Tomography Computed TomographyProstatic Neoplasms, Castration-ResistantWhole Body ImagingAgedBiomarkers, TumorGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedRadioisotopesRadiopharmaceuticalsBiomarkers, TumorGallium IsotopesGallium RadioisotopesHeterocyclic Compounds, 1-RingLutetiumOrganometallic CompoundsRadioisotopesRadiopharmaceuticals[177Lu]Lu-PSMA radiopharmaceutical therapyMRIPredictiveProstate cancerPSMA/PET CT

Identifiers

PMID42381110
PMCPMC13330063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.